Brentwood, TN, United States of America

Bridgid Hogan

This inventor holds 1 USPTO granted patent. Top assignees: Progenitor, Inc., Vanderbilt University. Active years: 1999.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bridgid Hogan: Innovator in Developmental Biology

Introduction

Bridgid Hogan is a prominent inventor based in Brentwood, TN (US). She has made significant contributions to the field of developmental biology, particularly through her research on endothelial cells. Her work has implications for understanding various biological processes and potential therapeutic applications.

Latest Patents

Hogan holds a patent for a novel invention titled "Nucleic acid encoding developmentally-regulated endothelial cell locus-1." This invention relates to a member of a new gene family known as developmentally-regulated endothelial cell locus-1 (del-1). The patent encompasses the del-1 nucleotide sequence, the Del-1 amino acid sequence, methods for expressing a functional gene product, and applications for utilizing the gene product. She has 1 patent to her name.

Career Highlights

Throughout her career, Bridgid Hogan has worked with notable organizations, including Progenitor, Inc. and Vanderbilt University. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.

Collaborations

Hogan has collaborated with esteemed colleagues such as Thomas Quertermous and H Ralph Snodgrass. These partnerships have enriched her research endeavors and fostered innovation in her field.

Conclusion

Bridgid Hogan is a distinguished inventor whose work in developmental biology has led to significant advancements in understanding endothelial cells. Her contributions continue to impact the scientific community and pave the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…